{
    "organizations": [],
    "uuid": "e44bfbc1ab135163c1c8a795b01246fbcf256c4a",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-initiator-pharma-raises-about-sek/brief-initiator-pharma-raises-about-sek-20-6-million-in-rights-issue-idUSASO0002YZ",
    "ord_in_thread": 0,
    "title": "BRIEF-Initiator Pharma Raises About SEK 20.6 Million In Rights Issue",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 5 (Reuters) - INITIATOR PHARMA A/S:\n* THE RIGHTS ISSUE OF UNITS HAS BEEN OVERSUBSCRIBED * ‍ISSUE WAS SUBSCRIBED TO APPROXIMATELY SEK 20,6 MILLION, RESPONDING TO A SUBSCRIPTION RATE OF APPROXIMATELY 108 PERCENT​\n* CONTRACT NOTES ARE PLANNED TO BE SENT OUT TODAY, ON APRIL 5TH, 2018.\n* SINCE RIGHTS ISSUE WAS OVERSUBSCRIBED, SUBSCRIPTION GUARANTEES ARE NOT ACTIVATED Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-04-05T15:32:00.000+03:00",
    "crawled": "2018-04-06T21:50:49.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "initiator",
        "pharma",
        "right",
        "issue",
        "unit",
        "oversubscribed",
        "subscribed",
        "approximately",
        "sek",
        "million",
        "responding",
        "subscription",
        "rate",
        "approximately",
        "contract",
        "note",
        "planned",
        "sent",
        "today",
        "april",
        "5th",
        "since",
        "right",
        "issue",
        "oversubscribed",
        "subscription",
        "guarantee",
        "activated",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}